Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Tranexamic Acid (TXA) in the Reduction of Post-operative Hematoma and Seroma in Patients Undergoing Panniculectomy or Abdominoplasty, a Pilot Study.

NCT04902950 is registered in ClinicalTrials.gov with The Reading Hospital and Medical Center as lead sponsor.

NCT NCT04902950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04902950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Tranexamic Acid (TXA) in the Reduction of Post-operative Hematoma and Seroma in Patients Undergoing Panniculectomy or Abdominoplasty, a Pilot Study.
Lead sponsor
The Reading Hospital and Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
August 17, 2020
Completion date
May 6, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominoplasty, panniculectomy